SPHK1 and cancer: In view of the absence of SPHK1 mutations across various cancer types, it is suggested that tumors exhibit a dependency on hyperactivation of SPHK signaling that confers survival and growth advantages to cancer cells, a phenomenon known as “non-oncogenic addiction” (Vadas et al., 2008).